Correlation Between Astellas Pharma and CSPC PHARMACEUTGR

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Astellas Pharma and CSPC PHARMACEUTGR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Astellas Pharma and CSPC PHARMACEUTGR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Astellas Pharma and CSPC PHARMACEUTGR ADR4, you can compare the effects of market volatilities on Astellas Pharma and CSPC PHARMACEUTGR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Astellas Pharma with a short position of CSPC PHARMACEUTGR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Astellas Pharma and CSPC PHARMACEUTGR.

Diversification Opportunities for Astellas Pharma and CSPC PHARMACEUTGR

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Astellas and CSPC is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Astellas Pharma and CSPC PHARMACEUTGR ADR4 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CSPC PHARMACEUTGR ADR4 and Astellas Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Astellas Pharma are associated (or correlated) with CSPC PHARMACEUTGR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CSPC PHARMACEUTGR ADR4 has no effect on the direction of Astellas Pharma i.e., Astellas Pharma and CSPC PHARMACEUTGR go up and down completely randomly.

Pair Corralation between Astellas Pharma and CSPC PHARMACEUTGR

Assuming the 90 days horizon Astellas Pharma is expected to under-perform the CSPC PHARMACEUTGR. But the stock apears to be less risky and, when comparing its historical volatility, Astellas Pharma is 1.93 times less risky than CSPC PHARMACEUTGR. The stock trades about -0.02 of its potential returns per unit of risk. The CSPC PHARMACEUTGR ADR4 is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  293.00  in CSPC PHARMACEUTGR ADR4 on August 25, 2024 and sell it today you would lose (61.00) from holding CSPC PHARMACEUTGR ADR4 or give up 20.82% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Astellas Pharma  vs.  CSPC PHARMACEUTGR ADR4

 Performance 
       Timeline  
Astellas Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Astellas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
CSPC PHARMACEUTGR ADR4 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in CSPC PHARMACEUTGR ADR4 are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, CSPC PHARMACEUTGR reported solid returns over the last few months and may actually be approaching a breakup point.

Astellas Pharma and CSPC PHARMACEUTGR Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Astellas Pharma and CSPC PHARMACEUTGR

The main advantage of trading using opposite Astellas Pharma and CSPC PHARMACEUTGR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Astellas Pharma position performs unexpectedly, CSPC PHARMACEUTGR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSPC PHARMACEUTGR will offset losses from the drop in CSPC PHARMACEUTGR's long position.
The idea behind Astellas Pharma and CSPC PHARMACEUTGR ADR4 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stocks Directory
Find actively traded stocks across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories